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LETTER TO THE EDITOR

Cough to Dyspnea to Acute
Respiratory Distress Syndrome
Dear Editor:
The outbreak of the novel coronavirus-2019
(COVID-19) was initially reported in Wuhan, China in
December 2019 and has since rapidly spread globally.
This has developed into a pandemic that has become
a global health emergency effecting well-being, economic stability, and international societies. COVID-19
commonly clinically manifests as acute respiratory distress. Other clinical ﬁndings include and are not limited
to acute thrombosis, gastrointestinal tract dysfunction,
especially diarrhea, and liver dysfunction.1,2 The transmission route of virus is through respiratory droplets
and fomite contact. The most accurate diagnostic test
has been nasal and pharyngeal swabs to detect viral
RNA. Furthermore, computed tomography has the
most sensitivity with correlation to clinical symptoms,
demonstrating peripheral ground glass opacities.3 We
present one of the ﬁrst cases of COVID-19 in our
healthcare facility that presented with high clinical suspicion for the disease, however, the patient initially
tested negative.
We describe a 52-year-old male with a past medical
history of chronic kidney disease, hypertension, who presented to the hospital for fevers, chills, nausea, and diarrhea. He initially stated having intermittent nausea for 2
weeks, which developed into a headache that progressed to fevers and chills over 4-5 days. The patient
denied recent travel or contact with anyone sick at
home; however, he’s a healthcare employee and comes
into contact with patients. On presentation, he was
febrile, with pulmonary exam signiﬁcant for course
breath sounds in bilateral lung ﬁelds. Chest x-ray
revealed bibasilar atelectasis (Fig. 1). Bloodwork was signiﬁcant for lymphopenia, azotemia, transaminitis and elevated ferritin. The patient became a high-risk person
under investigation for COVID-19 given his clinical
presentation and possibility of viral transmission via sick
contacts through occupation. COVID-19 RNA nasal and
pharyngeal swabs were obtained and resulted negative
in 2 days. However, due to high clinical suspicion, the
patient was retested for COVID-19. Other complications
arose, such as acute on chronic renal failure requiring
hemodialysis. On day 3, repeat chest x-ray showed
development of multifocal airspace opacities including
focal airspace opacities in bilateral upper lobes (Fig. 2).
He was started on broad spectrum antibiotics for
possible pneumonia. Throughout the hospital course,
the patient had several bouts of hypoxia requiring escalation of supplemental oxygen. On day 6, he developed
acute respiratory failure requiring ventilator support. The
patient was unable to maintain adequate oxygenation
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while ventilated and the family decided to compassionately extubate. On day 7, after the patient passed, the
retest for COVID-19 returned positive.
This pandemic has demanded a steep learning
curve on COVID-19 epidemiology, clinical presentation, diagnosis and treatment. The gold standard for
detecting viruses is based on rapid detection, using
real-time reverse transcription polymerase chain reaction (RT-PCR) for detection of SARS-CoV-2 RNA.4 The
COVID-19 PCR RNA test has about a 70% sensitivity
and if high suspicion is present, the clinical picture
needs to be taken into account.5 The most commonly
tested area is the throat, which has pharyngeal virus
shedding at its highest point during day 4 of symptoms.6 Testing patients’ different anatomical sites contribute to false negative results due to variation of viral
load kinetics in the nasal cavity, pharynx, or sputum.7
Other contributing factors to false negative results
include improper collection techniques, low viral RNA
load or inoculation.4
Cycle threshold (Ct) of the PCR test has been
proposed in multiple studies to be of high clinical
value in determining infectivity of a given patient.8
Unfortunately Ct is not commonly reported or readily
available to providers in our hospital. Serology testing for antibodies are also widely available, and indicate the patient has been infected, may still be
infected, or has mounted some degree of an immune
response to SARS-CoV-2. The Centers for Disease
Control and Prevention has guidelines to assist in
interpreting the serology test and RNA PCR test

FIGURE 1. Chest X-ray showing basilar subsegmental atelectasis.

THE AMERICAN JOURNAL OF THE MEDICAL SCIENCES
VOLUME 361 NUMBER 3 MARCH 2021

Downloaded for Anonymous User (n/a) at Henry Ford Hospital / Henry Ford Health System (CS North America) from ClinicalKey.com by
Elsevier on April 22, 2021. For personal use only. No other uses without permission. Copyright ©2021. Elsevier Inc. All rights reserved.

Cough to Dyspnea to Acute Respiratory Distress Syndrome

FIGURE 2. Chest X-ray showing stable cardiomegaly. Development of multifocal airspace opacities including
focal airspace opacities now seen within the bilateral upper lobes along with worsening focal airspace opacity
in the right lung base and increasing consolidative changes in the left lung base.

results. Additionally, antigen tests detecting viral
proteins are also coming into production, although
they are much less sensitive with higher potential for
false negative results.9
During this pandemic, test results drastically change
not only patient care, but also cause mass effect on the
hospital, health system and community. There is a high
demand for further research on viral replication, immunity
and viral shedding. Further research must be applied to
optimize the timing of PCR testing in patients with suspected infection to avoid false negative results and mitigate spread of infection.
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